Correction: the conference id for Optomed’s January-June 2023 half year report telephone conference has changed

Optomed Plc Press Release 3 August 2023 at 11.00, Helsinki

Correction: the conference id for Optomed’s January-June 2023 half year report telephone conference has changed

The conference id for the Optomed Q2 telephone conference has changed. The new conference id is 179 385 659#.

Optomed will publish its January-June 2023 half year report on 4 August 2023 approximately at 9.00 EEST.

A telephone conference for analysts, investors and media will be arranged on the publishing day at 11.00 EEST/10.00 CET. The event will be held in English. The presentation material will be available at www.optomed.com/investors 10.00 EEST at the latest.

The participants are requested to register for the call in advance by email to sakari.knuutti@optomed.com.

Please see the call-in numbers below:

FI +358 9 8562 6300

FR +33 1 70 99 53 92

SE +46 8 505 218 52

UK +44 20 3321 5273

US +1 646 838 1719

The conference id is179 385 659#.

Please note that by dialling in to the conference call, the participant agrees that personal information such as name and company name will be collected.

Optomed Plc

Further enquiries

Sakari Knuutti, CFO, Optomed Plc, sakari.knuutti@optomed.com, +358 50 562 4077

Optomed in Brief 

Optomed is a Finnish medical technology company and one of the leading providers of handheld fundus cameras. Optomed combines handheld screening devices fundus cameras with software and artificial intelligence with the aim to transform the diagnostic process of eye-diseases such as rapidly increasing diabetic retinopathy. In its business Optomed focuses on eye-screening devices and software solutions related R&D in Finland and sales through different channels in over 60 countries.